Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prophylactic treatment effects on inhibitor risk: experience in one centre.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 Mar 2005

Morado M, Villar A, Jiménez Yuste V, Quintana M, Hernandez Navarro F

Abstract excerpt

Nowadays, the elective treatment for children with haemophilia is prophylaxis. There is a common consensus that this modality of therapeutic approach is not associated with a higher risk of inhibitor development. We analysed the inhibitor incidence in 50 haemophiliac children and its relationship with mutations, type of clotting factor used and treatment modality. There was a significant correlation between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Factors
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor VIII

Share to Hemophilia A

Share to Immune Tolerance

Share to Infant

Share to Injections, Intravenous

Share to Treatment Outcome

Source

Identifiers

PMID: 15810907
DOI: 10.1111/j.1365-2516.2005.00921.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prophylactic treatment effects on inhibitor risk: experience in one centre.PMID 15810907Read ↗

Treatment related factors and inhibitor development in children with severe haemophilia A.Semantic proximity Read ↗

Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland.Semantic proximity Read ↗

Environmental risk factors for inhibitor development in children with haemophilia A: a case-control study.Semantic proximity Read ↗

Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies.Semantic proximity Read ↗

Assessing risk factors: prevention of inhibitors in haemophilia.Semantic proximity Read ↗

Genetic risk factors for inhibitors in haemophilia A.Semantic proximity Read ↗

Inhibitor Risk Stratification and Individualized Treatment in Patients With Nonsevere Hemophilia A: A Single-Institution Practice Audit.Semantic proximity Read ↗

Prophylaxis for severe hemophilia: experience from Europe and the United States.Semantic proximity Read ↗

Risk factors for inhibitor development in hemophilia A.Semantic proximity Read ↗

The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors.Semantic proximity Read ↗

Incidence and risk factors for inhibitor development in previously untreated severe haemophilia A patients born between 2005 and 2010.Semantic proximity Read ↗

Key issues in inhibitor management in patients with haemophilia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.